• A Program of Hope

    The IMP’s multidisciplinary team combines top-notch care with a caring and supportive environment to improve quality of life for patients and families.

    LEARN MORE ASK A QUESTION

  • Best Possible Treatment

    The IMP’s state-of-the-art technology and surgical interventions can significantly extend and improve the lives of patients with mesothelioma.

    LEARN MORE ASK A QUESTION

  • Working Toward a Cure

    IMP staff work collaboratively to understand how and why mesothelioma develops and translate those findings into improved patient care.

    LEARN MORE ASK A QUESTION

SCHEDULE AN APPOINTMENT: Call 617-732-5922 or

Schedule Online
  • slider1
  • The Lobby at Brigham & Women's Hospital
  • The IMP Staff

IMP’s Philosophy of Personalized Mesothelioma Treatment

The specialists at the International Mesothelioma Program bring more than 20 years of clinical and research experience into focus to achieve one goal – providing quality life extension leading to a cure. Our team includes surgeons, medical oncologists, radiation oncologists, anesthesiologists, pathologists, intensivists, nurses, physician assistants, pharmacists, social workers, chaplains, nutritionists, physical therapists, respiratory therapists, psychologists, and other clinicians. We work together to offer world-class care, personalized to address the unique needs of every patient, in a supportive and compassionate environment.

Common Questions About Mesothelioma Treatment

Who will my doctors be?

Clinicians, researchers, and supportive staff all work together, led by IMP Director Raphael Bueno, MD, a world-renowned mesothelioma specialist.

Read More

What kinds of treatment are available?

Options include surgery, chemotherapy, radiation therapy, and combined approaches that use several types of therapy (called multimodality therapy).

Read More

Besides clinical care, what other services are offered?

Our supportive staff includes a social worker, chaplains, and a program coordinator who provide emotional, spiritual, and practical help for patients and families.

Read More

How do I become a patient?

The first step is to call the Brigham and Women’s Hospital Division of Thoracic Surgery (1-617-732-5922) and ask to speak with a New Patient Coordinator.

Read More

Let Our Team Answer Your Questions:

SCHEDULE AN APPOINTMENT NOW SEND US A QUESTION ONLINE
research img

Emerging Research

Genomic Research Identifies Potentially Useful Markers in Mesothelioma

The International Mesothelioma Program’s (IMP) genomic analysis team has identified and validated multiple new mutations and chromosomal rearrangements in the mesothelioma genome that may potentially improve therapeutic decision-making for mesothelioma, and indeed for all cancers. Their findings represent the latest discovery from the IMP’s genome project, a collaborative effort to discover mutations associated with mesothelioma that potentially may be valuable as markers for diagnosis, prognosis, or therapy.

IMP’s Latest Research

Dr Raphael Bueno analyzing data

Epidemiology

April 30, 2013 by William G. Richards, PhD

The most identifiable cause of mesothelioma is exposure to asbestos, primarily through occupational contact. The majority of epidemiologic surveys have revealed a prior exposure to asbestos in approximately 70 to 80 percent of all cases of mesothelioma. Increased mesothelioma risk has been documented among workers in asbestos mines, insulation manufacture and installation, construction, shipbuilding, railroad […]

Lung Scan

The Role of Asbestos

April 30, 2013 by Assunta DeRienzo, PhD

In the late 19th century, asbestos fibers became more popular among manufacturers and builders because their chemical, electrical and heat resistant properties make them very useful as building and insulation material. However, asbestos fiber inhalation can lead to neoplastic diseases such as malignant mesothelioma. In the mid 1980s, most uses of asbestos have been banned […]

research-img3

Clinical Trials

April 30, 2013 by William G. Richards, PhD

Clinical trials are formalized research studies for determining the safety and effectiveness of new treatments. Generally they are prospective, meaning that rules for who can participate, how the research is conducted, what data are collected and how the results are to be interpreted are specified in advance. The rules are designed to minimize predictable sources […]

IMP Stories of Survival

stories1

Dorothea Consolini

New Hartford, Connecticut
Diagnosed 2001

“I went to the hospital with no real thought of what might happen.I just knew I’d be coming back home. I was determined to move ahead and get through it.”

stories2

Sissy Hoffman

Whitemarsh Island, Georgia
Diagnosed 1996

“The IMP team has saved my life, and I hope I am able to pay it forward.”

stories3

Josephine Formica

Florida
Husband diagnosed 2009

“The IMP team is like family when you are far from home, and they even make you feel a little bit like you are at home, in a way. They seem to miraculously appear just when you need them.”

stories4

Finnbogi Olafsson

Iceland
Diagnosed 2011

“The best thing about this journey is to know how many good friends and family we have – people who were willing to do everything they could to help out.”